https://www.selleckchem.com/pr....oducts/incb084550.ht
Novel health promotion and treatment uptake initiatives will be necessary to ensure Australia meets 2030 hepatitis C elimination targets. Increasing treatment uptake will be assisted by a better understanding of the treatment experience and patient-perceived benefits. This study describes the perceived physical health benefits from direct-acting antiviral (DAA) hepatitis C treatment among people who inject drugs in Melbourne, Australia. Twenty participants were recruited from a community treatment trial and community health clinics.
Like
Comment
Share
